| Original language | English |
|---|---|
| Pages (from-to) | 338 - 341 |
| Number of pages | 4 |
| Journal | American Journal of Clinical Oncology |
| Volume | 32 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2009 |
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer (CRPC).
Carmel Pezaro, Mark Rosenthal, Howard Gurney, Ian Davis, Craig R Underhill, Michael J Boyer, Dusan Kotasek, Benjamin Solomon, Guy Toner
Research output: Contribution to journal › Article › Research › peer-review
48
Citations
(Scopus)
